Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Recs

0
Player Avatar 21popsontop (< 20) Submitted: 10/4/2010 3:23:03 PM : Outperform Start Price: $38.86 COV Score: +21.05

Has the look of value

Featured Broker Partners


Advertisement